BRIAN CHERNOFF, M.D.

Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use

Transitional care management services for problem of at least moderate complexity

Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

Established patient office or other outpatient visit, 30-39 minutes

New patient office or other outpatient visit, 30-44 minutes

Established patient office or other outpatient visit, 20-29 minutes

Aspiration and/or injection of fluid from large joint

Influenza vaccine split virus, preservative free

Established patient office or other outpatient visit, 10-19 minutes

Injection of trigger points, 1-2 muscles

Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and

Removal of impacted ear wax

Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a

Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza

Injection, triamcinolone acetonide, not otherwise specified, 10 mg

Administration of influenza virus vaccine

Administration of pneumococcal vaccine

Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage

Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report

Urinalysis, manual test